Shanghai's SARI Pays $359M for Italian Cancer Biopharma NMS Post author:Sam Post published:December 28, 2017 Post category:BioPharma The parts expect the closing in the first quarter 2018. Source: BioSpace You Might Also Like Can-Fite BioPharma CEO Dr. To Present As Expert Speaker At Europe In Frankfurt, Germany On October 12, 2017 October 8, 2017 MabVax Therapeutics Presents Two Posters At The AACR Annual Meeting On A Novel Radioimmunotherapy Treatment For Pancreatic Cancer April 4, 2017 XW Laboratories Inc. Secures Over $17M Series B Financing Led By And September 19, 2017
Can-Fite BioPharma CEO Dr. To Present As Expert Speaker At Europe In Frankfurt, Germany On October 12, 2017 October 8, 2017
MabVax Therapeutics Presents Two Posters At The AACR Annual Meeting On A Novel Radioimmunotherapy Treatment For Pancreatic Cancer April 4, 2017
